You'll hear more controversy about ezetimibe (Vytorin, Zetia)

December 2009

You'll hear more controversy about ezetimibe (Vytorin, Zetia).

The latest data suggest that ezetimibe (Zetia) doesn't reduce atherosclerosis as well as niacin...when added to a statin.

This has experts scratching their heads. Ezetimibe lowers LDL better than niacin...and the current thinking is "lower is better."

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote